Back to search

Article

Multiomics approach identifies SERPINB1 as candidate progression biomarker for Spinocerebellar Ataxia type 2

2025-04-20

Abstract excerpt

<h4>Background</h4> Spinocerebellar ataxia type 2 (SCA2) is a polyglutamine disorder, and variants in its disease protein Ataxin-2 act as modifiers in the progression of Amyotrophic Lateral Sclerosis. There are no reliable molecular progression biomarkers for SCA2. <h4>Objectives</h4> The aim of this study was to define novel molecular progression biomarker candidates for SCA2. <h4>Methods</h4> Using cerebellar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
785517ee-0d2a-5953-9c9e-170333619316
DOI
10.1101/2025.04.18.649103
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multiomics approach identifies SERPINB1 as candidate progression biomarker for Spinocerebellar Ataxia type 2DOI 10.1101/2025.04.18.649103
Select a neighboring publication to make it the new centre.